Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

MRNS

Marinus Pharmaceuticals (MRNS)

Marinus Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MRNS
DateTimeSourceHeadlineSymbolCompany
01/08/20253:41PMEdgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:MRNSMarinus Pharmaceuticals Inc
01/07/20256:15PMEdgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
01/02/20252:25PMEdgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:MRNSMarinus Pharmaceuticals Inc
01/02/20252:25PMEdgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:MRNSMarinus Pharmaceuticals Inc
12/30/20246:11AMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:MRNSMarinus Pharmaceuticals Inc
12/30/20246:11AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
12/30/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
12/30/20246:00AMBusiness WireImmedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.NASDAQ:MRNSMarinus Pharmaceuticals Inc
12/23/20243:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
12/10/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
12/10/20242:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
11/15/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
11/14/20245:39PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
11/14/20242:04PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
11/14/202411:24AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
11/14/20248:34AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
11/12/20243:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRNSMarinus Pharmaceuticals Inc
11/12/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
11/12/20243:00PMBusiness WireMarinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
11/01/20247:30PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
11/01/20247:30PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
11/01/20247:30PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
10/24/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
10/24/20247:00AMBusiness WireMarinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic AlternativesNASDAQ:MRNSMarinus Pharmaceuticals Inc
10/17/20246:00AMBusiness WireMarinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual MeetingNASDAQ:MRNSMarinus Pharmaceuticals Inc
10/15/20243:00PMBusiness WireMarinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration RegimensNASDAQ:MRNSMarinus Pharmaceuticals Inc
10/09/20246:00AMBusiness WireMarinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual MeetingNASDAQ:MRNSMarinus Pharmaceuticals Inc
10/08/20243:04PMBusiness WireMarinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:MRNSMarinus Pharmaceuticals Inc
10/02/20246:56AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
09/20/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MRNS

Your Recent History

Delayed Upgrade Clock